A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
Clinical trial NCT06799286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06799286
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-07
- Primary completion
- 2027-05-26
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.